Endovascular Treatment of Thoracic Aortic Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 170 participants.
Also called NCT00583817
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 170 participants
- Registry
-
NCT00583817
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT00583817. Non-randomized; no masking; primary purpose treatment. Start 2018-10-25 (actual); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovascular Treatment of Thoracic Aortic Disease
- Acronym
- EVOLVE Aorta
- Condition
- Thoracic Aortic Aneurysms
- Condition
- Dissecting, Aneurysm
- Condition
- Ascending Aorta Aneurysm
- Condition
- Aortic Arch; Aneurysm, Dissecting
- Condition
- Ascending Aortic Dissection
- Condition
- Thoracoabdominal Aortic Aneurysm
- Condition
- Renal Artery Aneurysm
- Condition
- Superior Mesenteric Artery Aneurysm
- Condition
- Aortic Dissection
- Intervention (Device)
- Endovascular stent-graft implantation
- Lead sponsor
- Matthew Eagleton
- Collaborator
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct00583817- Content hash
459772e9ec08a9fde90c6d69c9f9a1dd621510cb7dbd44d6ac3d1db7332fe190